CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to NKTX

Fludarabine, Cyclophosphamide

Phase 2
Nkarta, Inc. (NKTX)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Apr '27
NKTXPhase 2

Fludarabine, Cyclophosphamide Phase 2 Est. Readout

Fludarabine, Cyclophosphamide
Apr 2027~STALE
CT.gov
00%
Drug Information

Target Indication

Lupus Nephritis

Clinical Trial

NCT06557265

Last updated: 2/13/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.